Cellular proteostasis in neurodegeneration A Kurtishi, B Rosen, KS Patil, GW Alves, SG Møller Molecular neurobiology 56, 3676-3689, 2019 | 177 | 2019 |
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases I Basak, KS Patil, G Alves, JP Larsen, SG Møller Cellular and Molecular Life Sciences 73, 811-827, 2016 | 116 | 2016 |
Parkinson's disease and age: the obvious but largely unexplored link R Abdullah, I Basak, KS Patil, G Alves, JP Larsen, SG Møller Experimental gerontology 68, 33-38, 2015 | 108 | 2015 |
Mouse ghrelin‐O‐acyltransferase (GOAT) plays a critical role in bile acid reabsorption K Kang, J Schmahl, JM Lee, K Garcia, K Patil, A Chen, M Keene, ... The FASEB Journal 26 (1), 259-271, 2012 | 38 | 2012 |
Combinatory microRNA serum signatures as classifiers of Parkinson's disease KS Patil, I Basak, I Dalen, E Hoedt, J Lange, KA Lunde, Y Liu, OB Tysnes, ... Parkinsonism & Related Disorders 64, 202-210, 2019 | 35 | 2019 |
A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells SGM Ketan S. Patil , Indranil Basak , Ramavati Pal, Hsin-Pin Ho, Guido Alves ... PLoS ONE 10 (12), 2015 | 31 | 2015 |
Arabidopsis AtPARK13, which confers thermotolerance, targets misfolded proteins I Basak, R Pal, KS Patil, A Dunne, HP Ho, S Lee, D Peiris, ... Journal of Biological Chemistry 289 (21), 14458-14469, 2014 | 23 | 2014 |
PARK13 regulates PINK1 and subcellular relocation patterns under oxidative stress in neurons KS Patil, I Basak, S Lee, R Abdullah, JP Larsen, SG Møller Journal of Neuroscience Research 92 (9), 1167-1177, 2014 | 18 | 2014 |
t (14; 19)(q32; q13) incidence and significance in B‐cell lymphoproliferative disorders RJ Kelly, D Wright, K Patil, M Chapple, SS Jalihal, SL Barrans, ... British journal of haematology 141 (4), 561-563, 2008 | 12 | 2008 |
Subcellular Parkinson’s disease-specific alpha-synuclein species show altered behavior in neurodegeneration R Abdullah, KS Patil, B Rosen, R Pal, S Prabhudesai, S Lee, I Basak, ... Molecular neurobiology 54, 7639-7655, 2017 | 9 | 2017 |
Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential TE Mullen, R Abdullah, J Boucher, AS Brousseau, NK Dasuri, NT Ditto, ... Antibody Therapeutics 4 (3), 185-196, 2021 | 8 | 2021 |
A novel paper‐based microfluidic device and UV‐visible spectroscopy coupled method for the field detection and analysis of seized marijuana samples R Krishna, K Patil, A Dixit, J Joseph, A Pandey Applied Research 2 (4), e202200068, 2023 | 3 | 2023 |
Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform MB Shapiro, J Boucher, A Brousseau, A Dehkharghani, J Gabriel, ... Antibody Therapeutics 6 (3), 211-223, 2023 | 1 | 2023 |
Circulating serum microRNA biomarkers and methods for Alzheimer's disease diagnosis SG Moller, KS Patil, GW Alves US Patent 11,634,775, 2023 | 1 | 2023 |
Biomarker and target discovery in Parkinson's disease KS Patil St. John's University (New York), 2016 | 1 | 2016 |
The Serine Protease PARK13 Degrading Misfolded Parkinson's Disease Proteins And Confers Cellular Protection I Basak, K Patil, JP Larsen, S Møller The FASEB Journal 29, 894.6, 2015 | 1 | 2015 |
Circulating serum microrna biomarkers and methods for parkinson's disease prognosis SG Moller, I Basak, K Patil, JP Larsen, GW Alves US Patent App. 18/452,778, 2024 | | 2024 |
Circulating serum cell-free dna biomarkers and methods SG Møller, K Patil US Patent App. 18/450,103, 2023 | | 2023 |
Circulating serum microrna biomarkers and methods SG Moller, I Basak, K Patil, JP Larsen US Patent App. 18/045,065, 2023 | | 2023 |
Circulating serum cell-free DNA biomarkers and methods SG Møller, K Patil US Patent 11,767,562, 2023 | | 2023 |